Johnson & Johnson Asks FDA To Authorize Vaccine

Johnson & Johnson has applied for emergency use authorization for its COVID vaccine, which requires only a single dose and can be stored in regular refrigerators. This vaccine is 66% effective against moderate and severe COVID cases, which is lower than Pfizer and Moderna's 95% efficacy. However, its logistical advantages and complete protection against hospitalizations and deaths 28 days post-vaccination make it a strong contender, especially for vaccinating hard-to-reach populations.

What is a key difference between the Johnson and Johnson vaccine and those from Pfizer and Moderna?

• Johnson and Johnson requires only one dose.

• Johnson and Johnson requires two doses.

• Johnson and Johnson needs ultracold storage.

• Johnson and Johnson is 95% effective.

How effective is the Johnson and Johnson vaccine in preventing moderate and severe COVID cases?

• 95%

• 66%

• 80%

• 50%

What is one logistical advantage of the Johnson and Johnson vaccine?

• It requires ultracold storage.

• It can be stored in regular refrigerators.

• It needs to be administered in two doses.

• It is more expensive than other vaccines.

What protection does the Johnson and Johnson vaccine offer 28 days after vaccination?

• Complete protection against hospitalizations and deaths.

• Protection only after a second dose.

• No protection against COVID-19.

• Partial protection against COVID-19.

Why might the Johnson and Johnson vaccine be preferred for hard-to-reach populations?

• It is less effective than other vaccines.

• It needs special storage conditions.

• It can be administered more quickly and easily.

• It requires two doses.